Eight-ounce scanner assesses heart function.
The U.S. Food & Drug Administration (FDA) has awarded 510(k) clearance to the hand-held ultrasound platform Kosmos, produced by the developer EchoNous.
By using machine learning, Kosmos can imitate humans’ learning and decision-making processes, according to the company. The 8-oz ultrasound tool has embedded and synchronized ECG and digital auscultation. Currently, the tool measures systolic heart function.
In addition, EchoNous has side-stepped the need for cloud connectivity with the Kosmos Bridge, a tablet that accompanies the platform. All artificial intelligence functions run on the tablet, ensuring there are no service failures during scans, EchoNous officials said. It is also designed to connect with a health system's IT system without a need for internet connectivity.
According to EchoNous officials, the Kosmos platform has been tested with more than 300 patients in acute care settings in the United States, Canada, Europe, and Japan. It will be available in the U.S. market for less than $10,000.
As a next step, company officials said, EchoNous plans to file for FDA clearance for a trio of algorithms that will allow users use machine learning algorithms to grade image quality, guide their technique, and label heart anatomy.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
Stroke MRI Study Assesses Impact of Motion Artifacts Upon AI and Radiologist Lesion Detection
July 16th 2025Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.